BMC Biotechnology

Featured article: Development of plant-produced protein body vaccine candidates for bluetongue virus

In this study, two novel protein body (PB) plant-produced vaccines were developed.

The results of this study indicate the possibility of using the bioflocculant produced by Arthrobacter humicola as a potential alternative to synthesized chemical flocculants in sewage waste water treatment and other industrial waste water.

Recent
Most accessed

Aims and scope

BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.

Editor

Ying Lou, BioMed Central

Section Editors

Ayelet Fishman,Technion
Joaquim M Cabral, Instituto Superior Tecnico
Dennis Claessen, Leiden University
Peter J Punt, TNO Microbiology & Systems Biology/Leiden University
Marko Radic, University of Tennessee
John J Rossi, Beckman Research Institute City of Hope
Igor Stagljar, University of Toronto
Neal C Stewart, University of Tennessee

Data Support Services pilot

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

Dennis Claessen

Dr. Claessen is an associate professor at Leiden University and section editor for BMC Biotechnology since 2015. His team addresses fundamental questions related to multicellular growth and development in filamentous bacteria called actinomycetes.

Meet our Section Editors

BMC Series blog

View feed

Sugar-sweetened drinks and your metabolism

Published on: 21 July 2017
Accelerating ethics review during disease outbreaks: what we can learn from West Africa’s Ebola Outbreak

Published on: 20 July 2017
A taxonomic revolution? A Q&A with Sandy Knapp on the impact of e-publications

Published on: 17 July 2017